VERA DevOps Helps a Major Biopharmaceutical Company Go Agile

With an Audit-Ready, End-to-End Solution

Moving away from a document-centric approach to approval lets you optimize your time-to-market while maintaining audit-ready levels of compliance. 

In the case study How VERA DevOps Helped One Biopharmaceutical Company Go Agile, we detail how we helped one of the world’s largest biopharmaceutical companies improve efficiency and streamline its technology investment. Thanks to VERA DevOps’ seamless integration with its existing tech stack, the client now enjoys benefits that include:

  • Real-time reporting and analytics for faster development
  • Control and governance of data across the DevOps life cycle
  • Compliance with 21 CFR Part 11 and related regulations

Learn why review and approval are about more than just e-signatures. Adopt an Agile, data-driven approach to eliminate your risk of human error and delays.